Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05330182 · ClinicalTrials.gov registry record · Phase 2

LMN-201 for Prevention of C. Difficile Infection Recurrence

A Phase 2 study of Clostridioides Difficile Infection, sponsored by Lumen Bioscience.

Recruiting
Registry status
Phase 2
Development phase
375
Enrollment target
16
Study locations

NCT05330182 is a Phase 2 study of Clostridioides Difficile Infection that is actively recruiting participants, run by Lumen Bioscience. The registered enrollment target is 375 participants, roughly in line with the 363-participant average among 6 other Clostridioides Difficile Infection trials with a reported enrollment target. The trial reports 16 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05330182, a Phase 2 study of Clostridioides Difficile Infection, is actively recruiting participants, sponsored by Lumen Bioscience.

RECRUITING
Registry status
Phase 2
Development phase
375 participants
Enrollment target
16
Study locations

Study Summary

This is a multisite study to evaluate the safety, tolerability, and efficacy of LMN-201 in participants recently diagnosed with CDI who are scheduled to receive or are receiving SOC antibiotic therapy against C. difficile.

Conditions Studied

Clostridioides Difficile Infection

Interventions

  • DRUG Placebo
  • DRUG LMN-201

Study Locations (16)

Connecticut

  • Bridgeport Hospital - Bridgeport
  • Gastroenterology Center of Connecticut - Hamden

Illinois

  • Metro Infectious Disease Consultants, LLC - Burr Ridge
  • DM Clinical Research - Oak Lawn

California

  • Kaiser Permanente - Escondido

Florida

  • GI PROS Research - Naples

Georgia

  • Metro Infectious Disease Consultants - Atlanta - Decatur

Idaho

  • Snake River Research - Idaho Falls

Kentucky

  • Baptist Health Research - Lexington

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 375 participants
Start Date 2024-08-29
Est. Completion 2027-12-01
Phase Phase 2

Sponsor

Lumen Bioscience

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05330182

The ClinicalTrials.gov registry entry for NCT05330182 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 375 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 363-participant average among 6 other Clostridioides Difficile Infection trials with a reported enrollment target. The listed sponsor is Lumen Bioscience, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Clostridioides Difficile Infection appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05330182 reports 16 study locations spanning 14 distinct geographic areas - top geographies include Connecticut, Illinois, California.

Frequently Asked Questions

What is clinical trial NCT05330182 about?

NCT05330182 is a clinical study titled "LMN-201 for Prevention of C. Difficile Infection Recurrence". This is a multisite study to evaluate the safety, tolerability, and efficacy of LMN-201 in participants recently diagnosed with CDI who are scheduled to receive or are receiving SOC antibiotic therapy against C. difficile.

What is the current status of trial NCT05330182?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 375 participants. The study started on 2024-08-29. Estimated completion is 2027-12-01.

What conditions does trial NCT05330182 study?

This clinical trial studies the following conditions: Clostridioides Difficile Infection.

What interventions are being tested in trial NCT05330182?

The interventions under investigation include: Placebo (DRUG), LMN-201 (DRUG).

Who is sponsoring clinical trial NCT05330182?

This trial is sponsored by Lumen Bioscience, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05330182 being conducted?

This trial has 16 study locations across California, Connecticut, Florida, Georgia, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Clostridioides Difficile Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Clostridioides Difficile Infection

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.